Corpus Intelligence IC Memo — ST. MARYS HOSPITAL 2026-04-26 09:38 UTC
IC Memo — ST. MARYS HOSPITAL
Investment Committee Memorandum | WI | 354 beds | Grade C | EBITDA uplift $29.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. MARYS HOSPITAL

CCN 520083 | DANE, WI | 354 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST. MARYS HOSPITAL is a 354-bed suburban community hospital in DANE, WI with $396.0M in net patient revenue and a -10.7% operating margin. The hospital serves a payer mix of 38.6% Medicare, 5.9% Medicaid, and 55.6% commercial.

Thesis: Undervalued. Our ML models identify $29.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.7% to -3.3% (+736bps).

Net Revenue HCRIS$396.0M
Current EBITDA COMPUTED$-42.2M
Operating Margin COMPUTED-10.7%
Occupancy HCRIS70.9%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS24.3%
Distress Probability ML44.5%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
20
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -10.7% places it below the state median. Among 20 size-comparable peers (177-708 beds), the median margin is 0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (177-708), prioritizing same-state peers. 20 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. MARYS HOSPITAL (Target)WI354$396.0M-10.7%
UNIVERSITY OF WI HOSPITALS & CWI644$2.68B3.2%
CHILDRENS HOSPITAL OF WISCONSIWI298$795.1M5.0%
MARSHFIELD MEDICAL CENTERWI194$765.7M-13.0%
MCHS EAU CLAIRE HOSPITALWI186$676.4M-5.5%
ST. VINCENT HOSPITALWI237$649.4M1.9%
ASPIRUS WAUSAU HOSPITALWI239$645.7M3.1%
AURORA BAYCARE MEDICAL CENTERWI190$558.0M17.6%
WAUKESHA MEMORIAL HOSPITALWI270$545.6M3.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $29.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$8.3M+210bp18mo
Cost to Collect4.5%2.5%$7.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.8M+122bp9mo
Clean Claim Rate88.0%96.0%$253K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$8.3M
Cost to Collect
$7.9M
Denial Rate Reduction
$7.8M
A/R Days Reduction
$4.8M
Clean Claim Rate
$253K
Total EBITDA Uplift$29.1M
Current EBITDA$-42.2M
+ RCM Uplift+$29.1M
Pro Forma EBITDA$-13.0M
Current Margin-10.7%
Pro Forma Margin-3.3%
WC Released (1x)$15.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-64.9M$13.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-64.9M$-6.5M0.00x-100.0%
Bull Case9.0x11.0x$-58.4M$68.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-58.4M$57.6M0.00x-100.0%
Bear Case11.0x10.0x$-71.4M$-111.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-71.4M$-145.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 20 hospitals with 177-708 beds
  • Same-state prioritization (n=21)
  • Comp margins: P25=-12.8% / P50=0.8% / P75=3.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.